|
|
Volumn 19, Issue 9, 1999, Pages
|
|
Emergence of low-molecular-weight heparins in cardiology
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBIN;
ARDEPARIN;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 12;
CLOPIDOGREL;
CYTOKINE;
DALTEPARIN;
ENDOTHELIN RECEPTOR ANTAGONIST;
ENOXAPARIN;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
HEPARIN DERIVATIVE;
HIRUDIN DERIVATIVE;
LOW MOLECULAR WEIGHT HEPARIN;
METALLOPROTEINASE INHIBITOR;
NADROPARIN;
REVIPARIN;
THROMBIN;
THROMBOXANE A2;
THROMBOXANE RECEPTOR BLOCKING AGENT;
TICLOPIDINE;
TINZAPARIN;
WARFARIN;
ACUTE HEART INFARCTION;
ANGINA PECTORIS;
ANTICOAGULATION;
ARTICLE;
BLOOD CLOTTING;
CORONARY RISK;
DRUG CHOICE;
DRUG EFFICACY;
HEPARINIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
THROMBOSIS;
UNSTABLE ANGINA PECTORIS;
ACUTE DISEASE;
CLINICAL TRIALS;
CORONARY DISEASE;
FIBRINOLYTIC AGENTS;
FORECASTING;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
|
|
EID: 0032884487
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.19.14.141S.31706 Document Type: Article |
|
Times cited : (3)
|
|
References (16)
|
